SEC 13F Intelligence

Mpm Bioimpact LLC / EWTX

Mpm Bioimpact LLC’s Edgewise Therapeutics Inc Position

Does Mpm Bioimpact LLC own Edgewise Therapeutics Inc (EWTX)? Yes — 1.66M shares worth $52M (+4.04% of its 13F portfolio) as of Q1 2026, up from 1.66M shares the prior filed quarter.

Position Value
$52M
Q1 2026
Shares
1.66M
% of Portfolio
+4.04%
Quarters Held
11
currently held

Position History EWTX

Reported value by quarter
Q3 ’22: $3MQ3 ’22Q2 ’23: $6MQ1 ’24: $8MQ1 ’24Q2 ’24: $13MQ3 ’24: $24MQ3 ’24Q4 ’24: $29MQ1 ’25: $24MQ1 ’25Q2 ’25: $23MQ3 ’25: $28MQ3 ’25Q4 ’25: $41MQ1 ’26: $52MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.66M$52M+4.04%
Q4 20251.66M$41M+4.70%
Q3 20251.72M$28M+4.57%
Q2 20251.72M$23M+3.91%
Q1 20251.11M$24M+4.18%
Q4 20241.08M$29M+4.09%
Q3 2024917.2K$24M+3.67%
Q2 2024740.7K$13M+2.07%
Q1 2024441.3K$8M+1.29%
Q2 2023712.8K$6M+1.11%
Q3 2022304.0K$3M+0.71%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mpm Bioimpact LLC’s full portfolio or all institutional holders of EWTX.